Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. (2022)

First Author: Marrone L
Attributed to:  Gene Therapy Innovation and Manufacturing Centre (GTIMC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14712598.2022.2012148

PubMed Identifier: 34904932

Publication URI: http://europepmc.org/abstract/MED/34904932

Type: Journal Article/Review

Volume: 22

Parent Publication: Expert opinion on biological therapy

Issue: 9

ISSN: 1471-2598